Microviable Therapeutics focuses on developing novel technologies and therapeutic products from the microbiota
Microviable Therapeutics has raised €1.5M across 1 funding round from 1 investor, most recently a Seed round in Apr 2022. Based in Gijon, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-21 | Seed | €1.5M |
| Inmunomet Intolerancia y Disbiosis SL |
| View deal → |
